TWO SIGMA INVESTMENTS, LP - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,129,000
+41.3%
288,780
-16.5%
0.00%
+50.0%
Q4 2020$799,000
-56.5%
345,706
+7.9%
0.00%
-71.4%
Q3 2020$1,838,000
+1897.8%
320,265
+932.7%
0.01%
+600.0%
Q1 2020$92,000
-86.9%
31,012
-81.6%
0.00%
-50.0%
Q4 2019$700,000
+3584.2%
168,602
+1528.7%
0.00%
Q2 2019$19,000
-74.7%
10,352
-75.6%
0.00%
Q1 2019$75,000
-34.2%
42,360
-10.4%
0.00%
Q4 2018$114,00047,2630.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,000,000$7,820,0004.09%
BVF INC/IL 6,631,051$25,927,0000.97%
EcoR1 Capital, LLC 6,082,200$23,781,0000.89%
GLOBEFLEX CAPITAL L P 1,009,125$3,946,0000.71%
Ikarian Capital, LLC 1,124,872$4,398,0000.36%
CHI Advisors LLC 218,510$854,0000.20%
Artal Group S.A. 2,500,000$9,775,0000.20%
DCF Advisers, LLC 139,701$546,0000.19%
Tibra Equities Europe Ltd 78,700$308,0000.10%
XTX Topco Ltd 50,569$198,0000.07%
View complete list of OVID THERAPEUTICS INC shareholders